Total Payments
$5,143
2024 Payments
$292.57
Companies
41
Transactions
338
Medicare Patients
4,738
Medicare Billing
$320,053
Payment Breakdown by Category
Food & Beverage$5,143 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,143 | 338 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,089 | 63 | $0 (2024) |
| Novo Nordisk Inc | $553.82 | 37 | $0 (2024) |
| PFIZER INC. | $490.45 | 33 | $0 (2021) |
| Amarin Pharma Inc. | $361.97 | 27 | $0 (2021) |
| Lilly USA, LLC | $304.22 | 21 | $0 (2021) |
| Amgen Inc. | $267.85 | 17 | $0 (2023) |
| Abbott Laboratories | $244.50 | 14 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $225.88 | 17 | $0 (2024) |
| Daiichi Sankyo Inc. | $179.51 | 14 | $0 (2018) |
| Allergan, Inc. | $160.78 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $292.57 | 17 | ABBVIE INC. ($183.22) |
| 2023 | $419.30 | 26 | ABBVIE INC. ($233.64) |
| 2022 | $697.83 | 43 | ABBVIE INC. ($341.29) |
| 2021 | $1,171 | 77 | AbbVie Inc. ($330.45) |
| 2020 | $587.75 | 37 | Allergan, Inc. ($139.67) |
| 2019 | $536.34 | 41 | PFIZER INC. ($163.29) |
| 2018 | $581.12 | 38 | PFIZER INC. ($116.94) |
| 2017 | $856.94 | 59 | Daiichi Sankyo Inc. ($166.71) |
All Payment Transactions
338 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device), Zilretta | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Pain Management | ||||||
| 08/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $1.60 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Respiratory | ||||||
| 07/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $34.11 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $34.90 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Oncology | ||||||
| 02/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: NEUROSCIENCE | ||||||
| 01/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Respiratory | ||||||
| 12/27/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: RESPIRATORY | ||||||
| 12/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $31.51 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Diabetes | ||||||
| 10/31/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Inflammation | ||||||
| 10/31/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 982 | 1,679 | $205,624 | $68,676 |
| 2022 | 13 | 1,076 | 1,777 | $225,559 | $74,500 |
| 2021 | 19 | 1,265 | 2,978 | $293,323 | $91,889 |
| 2020 | 21 | 1,415 | 3,174 | $263,391 | $84,988 |
Total Patients
4,738
Total Services
9,608
Medicare Billing
$320,053
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 268 | 647 | $109,870 | $33,966 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 176 | 228 | $53,916 | $15,516 | 28.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 86 | 86 | $21,099 | $10,270 | 48.7% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 49 | 49 | $3,920 | $1,608 | 41.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 193 | 296 | $1,480 | $1,441 | 97.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 50 | 50 | $2,000 | $1,391 | 69.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 22 | 32 | $3,876 | $1,314 | 33.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $4,260 | $1,247 | 29.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 11 | 11 | $880.00 | $862.40 | 98.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $800.00 | $567.60 | 71.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 25 | $662.50 | $195.51 | 29.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 15 | 17 | $680.00 | $161.84 | 23.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 28 | 36 | $1,410 | $122.76 | 8.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 30 | 160 | $770.00 | $14.35 | 1.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 262 | 609 | $103,527 | $32,657 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 207 | 297 | $71,006 | $20,448 | 28.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 99 | 99 | $24,349 | $12,284 | 50.4% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 58 | 59 | $4,720 | $1,833 | 38.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 28 | 42 | $5,381 | $1,807 | 33.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $4,833 | $1,553 | 32.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 58 | 59 | $2,360 | $1,545 | 65.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 223 | 344 | $2,030 | $1,016 | 50.1% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 43 | 126 | $1,575 | $605.24 | 38.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 37 | $977.46 | $217.96 | 22.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 18 | 21 | $840.00 | $192.74 | 22.9% |
About Dr. James Moore, DO
Dr. James Moore, DO is a Family Medicine healthcare provider based in Farmington, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134171531.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Moore, DO has received a total of $5,143 in payments from pharmaceutical and medical device companies, with $292.57 received in 2024. These payments were reported across 338 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($5,143).
As a Medicare-enrolled provider, Moore has provided services to 4,738 Medicare beneficiaries, totaling 9,608 services with total Medicare billing of $320,053. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Farmington, MO
- Active Since 05/16/2006
- Last Updated 08/15/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1134171531
Products in Payments
- UBRELVY (Drug) $446.86
- VRAYLAR (Drug) $383.73
- QULIPTA (Drug) $373.24
- Vascepa (Drug) $361.97
- TRULICITY (Drug) $294.22
- LYRICA (Drug) $247.13
- Ozempic (Drug) $235.76
- Aimovig (Biological) $220.81
- TRELEGY ELLIPTA (Drug) $151.56
- BREZTRI (Drug) $136.24
- NURTEC ODT (Drug) $123.61
- Proclaim IPG (Device) $95.33
- VIAGRA (Drug) $87.23
- XIFAXAN (Drug) $83.83
- Proclaim Family of SCS IPGs (Device) $82.03
- Saxenda (Drug) $81.91
- CHANTIX (Drug) $81.45
- AMRIX (Drug) $80.57
- Rybelsus (Drug) $77.37
- RYBELSUS (Drug) $72.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Farmington
Harold Mcfarling, D.o, D.O
Family Medicine — Payments: $121,257
Family Medicine $121,257
Dr. Paul Moniz, Do, DO
Family Medicine — Payments: $18,951
Family Medicine $18,951
Guy Roberts, D.o, D.O
Family Medicine — Payments: $17,599
Family Medicine $17,599
Dr. Barbara Wilhelm, M.d, M.D
Family Medicine — Payments: $10,359
Family Medicine $10,359
Dr. Brett Dickinson, M.d, M.D
Family Medicine — Payments: $9,823
Family Medicine $9,823
Dr. Sheldon Stern, Do, DO
Family Medicine — Payments: $8,399
Family Medicine $8,399